SR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials - Turner, NC; Swift, C; Kilburn, L (Clin Cancer Res, 2020)